|Articles|May 1, 2019
- BioPharm International-05-01-2019
- Volume 32
- Issue 5
BioPharm International, May 2019 Issue (PDF)
Click the title above to open the BioPharm International May 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Optimizing Diaphragm Valves to Improve Bioprocess Reliabilityover 6 years ago
What’s New in Upstream Technologiesover 6 years ago
FDA Faces Challenges After Gottliebover 6 years ago
Bioprocessing Facilities and FDA Inspection Problemsover 6 years ago
The Auditor Vs. Inspector Issueover 6 years ago
New Kit Identifies Endonuclease Impuritiesover 6 years ago
Multichannel Pipettes for 384-Well Platesover 6 years ago
Challenges with Successful Commercialization of Biosimilarsover 6 years ago
Single-Use for Downstream Chromatography: Benefit or Hindrance?Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
